Post a Free Blog

Submit A Press Release

At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO's Recent Stock Purchase Highlights Confidence in Breast...

Anixa Biosciences, Inc. (NASDAQ:ANIX) CEO’s Recent Stock Purchase Highlights Confidence in Breast Cancer Vaccine

Add to Favorite
Added to Favorite


Kumar Amit, CEO of Anixa Biosciences, Inc. (NASDAQ:ANIX), purchased 10,000 shares, increasing his total ownership to 569,925 shares.
Anixa’s innovative breast cancer vaccine targets ?-lactalbumin in malignant cells, aiming to revolutionize cancer prevention and treatment.
Despite financial challenges, ANIX’s low debt-to-equity ratio and strong current ratio suggest a stable foundation for its projects.

On June 4, 2025, Kumar Amit, CEO of Anixa Biosciences, Inc. (NASDAQ:ANIX), made a significant investment in his company by purchasing 10,000 shares of the company’s common stock at $2.85 each. This strategic acquisition increased his total ownership to 569,925 shares, demonstrating a strong belief in the company’s future prospects. Anixa, a pioneering biotechnology firm, is at the forefront of developing a breast cancer vaccine, a groundbreaking approach to cancer treatment.

Anixa’s breast cancer vaccine is a significant development in the field of cancer treatment. The vaccine specifically targets the protein ?-lactalbumin, found in malignant cells during breast cancer, activating the immune system to attack these cells. This innovative method was highlighted by Dr. Amit Kumar on NewsNation’s “Elizabeth Vargas Reports.” The company has completed enrollment for its Phase 1 clinical trial of the vaccine, developed in collaboration with the Cleveland Clinic. This trial, funded by the U.S. Department of Defense, is a critical step in demonstrating the vaccine’s effectiveness.

Despite its promising research, ANIX faces financial challenges, with a negative P/E ratio of -7.31 and an enterprise value to operating cash flow ratio of -11.41. The earnings yield is also negative at -13.68%, indicating current financial struggles. However, ANIX has a low debt-to-equity ratio of 0.0129 and a strong current ratio of 9.35, suggesting a solid ability to cover short-term liabilities. These financial metrics indicate that while ANIX faces challenges, it has a stable financial foundation to support its innovative projects.

Subscribe to get Latest News Updates

Latest News

You may like more
more